Alma Dangy’s practice focuses on all aspects of EU antitrust and competition law.
Alma joined the firm in 2022. Prior to joining Cleary, Alma worked at the European Commission in DG Trade.
Publications
“General Court Rejects ByteDance’s Application for Interim Measures,” Cleary Antitrust Watch blog, February 9, 2024
“Time to wake up for the sleeping drug industry: the General Court confirms that Teva and Cephalon’s modafinil pay-for-delay settlement agreement is contrary to Article 101 TFEU,” EU Law Live, November 3, 2023
